More from Renaissance Capital

Supernus Pharmaceuticals prices IPO at $5, raising $50 million

By Renaissance Capital,  May 01, 2012, 08:56:29 AM EDT

Supernus Pharmaceuticals, a former Shire sub developing improved drug formulations for epilepsy and ADHD, raised $50 million on Monday by offering 10 million shares at $5. The company had originally filed to offer 5.8 million shares at a range of $12 to $14 before filing an amendment last Friday revising deal terms to 11 million shares at an estimated listing price of $5. Supernus Pharmaceuticals plans to list on the NASDAQ under the symbol SUPN. Citi acted as lead manager on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, IPOs

Referenced Stocks:



Latest News Video

Iran Election Heats Up
Iran Election Heats Up              
The Latest On The Oklahoma Tornado
The Latest On The Oklahoma Tornado  
Kirsten Gillibrand Pleads To Stop Food Stamp Cuts
Kirsten Gillibrand Pleads To Stop F...
Vermont Gov. Signs "Death With Dignity" Bill Into Law
Vermont Gov. Signs "Death With Dign...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.47 0.04  0.30%
F $ 15 0.05  0.33%
SIRI $ 3.51 0.01  0.29%
CLWR $ 3.42 0.16  4.91%
YGE $ 3.65 0.55  17.74%
MSFT $ 35.04 0.04  0.11%
AMD $ 4.04 0.06  1.46%
CSCO $ 23.855 0.09  0.38%